Healio
SearchLoading
Healio
SearchLoading

American Academy of Ophthalmology Meeting
ByOsamah Saeedi, MD
ByAnthony DeFino
Fact checked byChristine Klimanskis, ELS

Read more

December 03, 2022
3 min watch
Save

VIDEO: Netarsudil increases episcleral venous flow

ByOsamah Saeedi, MD
ByAnthony DeFino
Fact checked byChristine Klimanskis, ELS

CHICAGO — In this Healio Video Perspective from the AAO meeting, Osamah Saeedi, MD, discusses the effects of netarsudil on episcleral venous flow in subjects with ocular hypertension and glaucoma suspects.

According to Saeedi, the study showed significant increases in episcleral venous flow and diameter at 1 hour after treatment with Rhopressa (netarsudil ophthalmic solution 0.02%, Alcon/Aerie). These effects persisted at 1 week.

Sources/Disclosures

Collapse
Source:

Saeedi O. Single-cell erythrocyte tracking in human subjects reveals increase in episcleral venous flow with netarsudil 0.02. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.

Disclosures: Saeedi reports receiving research support from Aerie, Heidelberg Engineering and Vasoptic Medical.

Read more from American Academy of Ophthalmology Meeting

View all

Read more about

netarsudil
glaucoma
intraocular pressure
 

Related Content